Form 4: Palatin Technologies CEO Carl Spana Boosts Stake with $150,000 Investment in Convertible Preferred Stock and Warrants

Palatin Technologies' President and CEO, Carl Spana, has acquired 1,500 shares of Series D Convertible Preferred Stock and 2,727,272 Series I warrants, signaling strong insider confidence.

Summary

• Carl Spana, President and CEO, and a Director of Palatin Technologies Inc. (PTN), acquired additional equity securities.
• The transaction occurred on June 13, 2025.
• Mr. Spana acquired 1,500 shares of Series D Preferred Stock for a total value of $150,000.
• Each share of Series D Convertible Preferred Stock has a stated value of $100 and is convertible into common stock at an initial conversion price of $0.11 per share.
• The 1,500 Series D Preferred Stock shares are convertible into 1,363,636 shares of common stock.
• Following this transaction, Mr. Spana beneficially owns 1,672,940 shares of Series D Preferred Stock.
• Mr. Spana also acquired 2,727,272 Series I warrants, which are exercisable at $0.11 per share.
• These warrants are exercisable upon obtaining stockholder approval as required by NYSE American and will expire five years after the Stockholder Approval Date.
• Following this transaction, Mr. Spana beneficially owns 3,060,655 Series I warrants.
• The Series D Preferred Stock and Series I warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a significant insider purchase by the CEO, indicating strong confidence in the company's future.

Positives

• The acquisition of additional equity by the President and CEO, Carl Spana, demonstrates strong insider confidence in the company's future prospects.
• The investment provides Palatin Technologies with $150,000 in capital.

Risks

• The exercisability of the Series I warrants is contingent upon obtaining stockholder approval, which is not guaranteed.
• The conversion of Series D Preferred Stock and exercise of Series I warrants at a low price of $0.11 per share could lead to significant dilution for existing common stockholders.

Future Outlook

The exercisability of the Series I warrants is dependent on future stockholder approval, which will determine when these derivative securities can be converted into common stock.

Industry Context

Insider purchases, particularly by a CEO, are often viewed as a positive signal in the biotechnology and pharmaceutical industries, where long development cycles and regulatory hurdles make management's confidence in future products and strategies particularly important.

Related Party Transactions

• The transaction involves the acquisition of company securities by Carl Spana, the President and CEO, and a Director, making it a related party transaction.

Stakeholder Impact

• Shareholders: May view the CEO's increased stake as a positive sign of confidence, potentially boosting investor sentiment. However, future conversion of preferred stock and exercise of warrants could lead to dilution.
• Company: Benefits from a $150,000 capital infusion from the CEO's investment.

Next Steps

• Palatin Technologies will need to obtain stockholder approval for the exercisability of the Series I warrants, as required by NYSE American.

Key Dates

Recommendation

Keywords

SEC Form 4, Insider Trading, Carl Spana, Palatin Technologies, PTN, Series D Preferred Stock, Series I Warrants, Convertible Securities, Equity Acquisition, CEO, Director, Biotechnology, Pharmaceutical